These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 25973085

  • 1. CD147 and MMP-9 expressions in type II/III adenocarcinoma of esophagogastric junction and their clinicopathological significances.
    Huang L, Xu AM, Peng Q.
    Int J Clin Exp Pathol; 2015; 8(2):1929-37. PubMed ID: 25973085
    [Abstract] [Full Text] [Related]

  • 2. Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan.
    Hosokawa Y, Kinoshita T, Konishi M, Takahashi S, Gotohda N, Kato Y, Daiko H, Nishimura M, Katsumata K, Sugiyama Y, Kinoshita T.
    Ann Surg Oncol; 2012 Feb; 19(2):677-83. PubMed ID: 21822549
    [Abstract] [Full Text] [Related]

  • 3. The prognostic relevance of parapyloric lymph node metastasis in Siewert type II/III adenocarcinoma of the esophagogastric junction.
    Wang JB, Lin MQ, Li P, Xie JW, Lin JX, Lu J, Chen QY, Cao LL, Lin M, Zheng CH, Huang CM.
    Eur J Surg Oncol; 2017 Dec; 43(12):2333-2340. PubMed ID: 28928013
    [Abstract] [Full Text] [Related]

  • 4. Adenocarcinoma of the esophagogastric junction and its background mucosal pathology: A comparative analysis according to Siewert classification in a Japanese cohort.
    Urabe M, Ushiku T, Shinozaki-Ushiku A, Iwasaki A, Yamazawa S, Yamashita H, Seto Y, Fukayama M.
    Cancer Med; 2018 Oct; 7(10):5145-5154. PubMed ID: 30239168
    [Abstract] [Full Text] [Related]

  • 5. [Comparison of clinicopathological features and prognosis between adenocarcinoma of esophagogastric junction and adenocarcinoma of gastric antrum].
    Zhu Z, Wang Y, Li F, Gao J, Han B, Wang R, Xue Y.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb 25; 22(2):149-155. PubMed ID: 30799537
    [Abstract] [Full Text] [Related]

  • 6. Novel abdominal approach for dissection of advanced type II/III adenocarcinoma of the esophagogastric junction: a new surgical option.
    Hu C, Zhu HT, Xu ZY, Yu JF, Du YA, Huang L, Yu PF, Wang LJ, Cheng XD.
    J Int Med Res; 2019 Jan 25; 47(1):398-410. PubMed ID: 30296865
    [Abstract] [Full Text] [Related]

  • 7. Lymphatic vessel invasion as a prognostic factor in patients with primary resected adenocarcinomas of the esophagogastric junction.
    von Rahden BH, Stein HJ, Feith M, Becker K, Siewert JR.
    J Clin Oncol; 2005 Feb 01; 23(4):874-9. PubMed ID: 15681533
    [Abstract] [Full Text] [Related]

  • 8. Prognostic impact of TAZ and β-catenin expression in adenocarcinoma of the esophagogastric junction.
    Sun L, Chen F, Shi W, Qi L, Zhao Z, Zhang J.
    Diagn Pathol; 2014 Jul 16; 9():125. PubMed ID: 25029906
    [Abstract] [Full Text] [Related]

  • 9. [Adenocarcinoma of the esophagogastric junction: prognostic factors and results of primary surgery].
    Bösing NM, Heise JW, Goretzki PE, Sarbia M, Röher HD.
    Chirurg; 2004 Nov 16; 75(11):1088-97. PubMed ID: 15168031
    [Abstract] [Full Text] [Related]

  • 10. Extranodal metastasis is a powerful prognostic factor in patients with adenocarcinoma of the esophagogastric junction.
    Zhang HD, Tang P, Duan XF, Chen CG, Ma Z, Gao YY, Zhang H, Yu ZT.
    J Surg Oncol; 2013 Dec 16; 108(8):542-9. PubMed ID: 24018956
    [Abstract] [Full Text] [Related]

  • 11. Adenocarcinoma of the esophagogastric junction in Japan.
    Yamamoto M, Baba H, Egashira A, Oki E, Ikebe M, Kakeji Y, Maehara Y.
    Hepatogastroenterology; 2008 Dec 16; 55(81):103-7. PubMed ID: 18507087
    [Abstract] [Full Text] [Related]

  • 12. Overexpression of EGFR as an Independent Prognostic Factor in Adenocarcinoma of the Esophagogastric Junction.
    Aratani K, Komatsu S, Ichikawa D, Ohashi T, Miyamae M, Okajima W, Imamura T, Kiuchi J, Nishibeppu K, Kosuga T, Konishi H, Shiozaki A, Fujiwara H, Okamoto K, Tsuda H, Otsuji E.
    Anticancer Res; 2017 Jun 16; 37(6):3129-3135. PubMed ID: 28551654
    [Abstract] [Full Text] [Related]

  • 13. Prognostic implications of RASAL1 expression in oesophagogastric adenocarcinoma.
    Knief J, Reddemann K, Lazar-Karsten P, Herhahn T, Petrova E, Wellner U, Thorns C.
    J Clin Pathol; 2017 Mar 16; 70(3):274-276. PubMed ID: 28011578
    [No Abstract] [Full Text] [Related]

  • 14. Clinical and prognostic features of E-cadherin in adenocarcinoma of the esophagogastric junction patients.
    Hu K, Zheng QM, Wang YP, Zhao MM, Sun ZG.
    Eur J Cancer Prev; 2023 Mar 01; 32(2):119-125. PubMed ID: 36484275
    [Abstract] [Full Text] [Related]

  • 15. [Clinical outcomes of surgical patients with types II and III adenocarcinoma of esophagogastric junction].
    Chen XF, Chen HN, Zhang B, Chen ZX, Hu JK, Wang F, Yang HX, Chen JP.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Mar 01; 43(2):289-92. PubMed ID: 22650050
    [Abstract] [Full Text] [Related]

  • 16. [Expression and clinical significance of DAPK1 and CD147 in esophageal squamous cell carcinoma].
    Wan Y, Wu XY.
    Zhonghua Zhong Liu Za Zhi; 2012 Jan 01; 34(1):44-8. PubMed ID: 22490855
    [Abstract] [Full Text] [Related]

  • 17. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
    Wang KL, Wu TT, Choi IS, Wang H, Resetkova E, Correa AM, Hofstetter WL, Swisher SG, Ajani JA, Rashid A, Albarracin CT.
    Cancer; 2007 Feb 15; 109(4):658-67. PubMed ID: 17211865
    [Abstract] [Full Text] [Related]

  • 18. Individualized surgical strategies for cancer of the esophagogastric junction.
    Stein HJ, Feith M, Siewert JR.
    Ann Chir Gynaecol; 2000 Feb 15; 89(3):191-8. PubMed ID: 11079787
    [Abstract] [Full Text] [Related]

  • 19. Is adenocarcinoma of the esophagogastric junction different between Japan and western countries? The incidence and clinicopathological features at a Japanese high-volume cancer center.
    Hasegawa S, Yoshikawa T, Cho H, Tsuburaya A, Kobayashi O.
    World J Surg; 2009 Jan 15; 33(1):95-103. PubMed ID: 18958523
    [Abstract] [Full Text] [Related]

  • 20. Lymph node metastases of adenocarcinoma of the esophagus and esophagogastric junction.
    Zhang X, Watson DI, Jamieson GG.
    Chin Med J (Engl); 2007 Dec 20; 120(24):2268-70. PubMed ID: 18167216
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.